SOLICITATION NOTICE
B -- Randomized Placebo-Controlled Study for Isoniazid Tuberculosis Preventive Therapy for HIV Infected Persons in Botswana
- Notice Date
- 3/14/2008
- Notice Type
- Solicitation Notice
- NAICS
- 541720
— Research and Development in the Social Sciences and Humanities
- Contracting Office
- Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- Reference-Number-000HCVJE-2008-53003
- Response Due
- 3/31/2008
- Archive Date
- 4/15/2008
- Point of Contact
- Zalerie Moore, Contract Specialist, Phone 770-488-2053, Fax 770-488-2688
- E-Mail Address
-
fkw7@cdc.gov
- Description
- In accordance with FAR Subpart 13.106-1(b) the Centers for Disease Control and Prevention(CDC)intends to issue a sole-source purchase order to Westat, Inc in Rockville, MD for $49,936.00.The contractor shall provide assistance and oversight to investigators on the conduct of the CDC funded clinical trails for randomized placebo controlled study of limited vs.continuous Isoniard Tuberculosis prevention therapy for HIV-infected persons in Botswana being held at eight(8)clinics located in Botswana. The contractor shall be responsible for verifying the following: (1)that human rights and subjects are protected:(2)the data is accurate, complete and verifiable; and(3)the trail is conducted in compliance with the protocol and any amendments, according to Good Clinical Practices (GCP).Westat shall make monitoring visits to the CDC funded clinical trail sites to ensure the clinical sites are being conducted according to GCP and other relevant clinical trial standards.Westat Incorporation has considerable experience working with Botswana, USA(BOTUSA)on this requirement. They have been working with this study since 2005 and have the trained professional staff necessary to perform the monitoring required by CDC in collaboration with the eight clinics throughout Botswana. Westat has prepared the recommendations and guidelines for the placebo study sites in Botswana. The information received in response to this notice will be considered solely for the purpose of determining whether or not to conduct a competitive procurement. Please send your documentation to Milton Weathers at the office identified above, by fax(770)488-2668 or email to zpp4@cdc.gov.Documentation should be received within fifteen(15)days after the date of publication of this synopsis to be considered by CDC. A determination by the CDC not to compete this proposed contract based upon responses to this notice is solely within discretion of the government.
- Place of Performance
- Address: Botswana
- Country: BOTSWANA
- Country: BOTSWANA
- Record
- SN01532642-W 20080316/080314223405 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |